Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Eyenovia Inc
(NQ:
EYEN
)
0.5820
+0.0357 (+6.53%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Eyenovia Inc
< Previous
1
2
3
4
Next >
Why Snap Shares Jumped 7%; Here Are 75 Biggest Movers From Yesterday
September 02, 2022
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
September 01, 2022
Via
Benzinga
Recap: Eyenovia Q2 Earnings
August 10, 2022
Eyenovia (NASDAQ:EYEN) reported its Q2 earnings results on Wednesday, August 10, 2022 at 04:05 PM. Here's what investors need to know about the announcement.
Via
Benzinga
Eyenovia's Earnings Outlook
March 25, 2022
Eyenovia (NASDAQ:EYEN) is set to give its latest quarterly earnings report on Monday, 2022-03-28. Here's what investors need to know before the announcement. Analysts estimate...
Via
Benzinga
Eyenovia's Novel Optejet® Dispenser Puts People's Eyes First
August 30, 2022
While traditional eye drop bottles require hand-eye coordination and deliver four to five times more medication than the human eye can hold, the Optejet® dispenser's human-centric design administers an...
Via
Newswire.com
Stocks That Hit 52-Week Lows On Thursday
August 25, 2022
On Thursday, 63 companies set new 52-week lows.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
August 24, 2022
Gainers Aridis Pharmaceuticals (NASDAQ:ARDS) shares moved upwards by 20.1% to $1.79 during Wednesday's after-market session. The market value of their outstanding shares is at $31.6 million.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
August 10, 2022
Via
Benzinga
Biotech Daily: Cancer Causing Impurities In Merck's Diabetic Drug, Vir Bio-GSK Shun FDA Submission Plans For COVID-19 Treatment, Aethlon's Monkeypox Trial
August 10, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Eyenovia's Earnings Outlook
August 09, 2022
Eyenovia (NASDAQ:EYEN) is set to give its latest quarterly earnings report on Wednesday, 2022-08-10. Here's what investors need to know before the announcement. Analysts estimate that Eyenovia will...
Via
Benzinga
Eyenovia: Q1 Earnings Insights
May 12, 2022
Eyenovia (NASDAQ:EYEN) reported its Q1 earnings results on Thursday, May 12, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Eyenovia missed estimated earnings by...
Via
Benzinga
Earnings Preview: Eyenovia
May 11, 2022
Eyenovia (NASDAQ:EYEN) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that Eyenovia will...
Via
Benzinga
Earnings Scheduled For March 28, 2022
March 28, 2022
Companies Reporting Before The Bell • LGL Group (AMEX:LGL) is likely to report quarterly earnings at $0.10 per share on revenue of $7.20 million.
Via
Benzinga
Eyenovia Raises 15M Via Equity To Advance MydCombi Program
March 04, 2022
Eyenovia Inc (NASDAQ: EYEN) has entered into a Securities Purchase Agreement with Armistice Capital Master Fund Ltd for gross proceeds of $15 million. The...
Via
Benzinga
The Daily Biotech Pulse: Ocugen Faces Regulatory Setback, vTv CEO Quits, Biogen-Eisai Make Headway With Second Alzheimer's Antibody Treatment In Japan
March 04, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Merck's Keytruda Evaluated In Combination With Microbiome Therapeutic In...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
December 14, 2021
Gainers Star Equity Hldgs (NASDAQ:STRR) s...
Via
Benzinga
4 Penny Stocks Insiders Are Buying
November 04, 2021
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider...
Via
Benzinga
Attention Biotech Investors: Mark Your Calendar For November PDUFA Dates
November 02, 2021
The loaded Prescription Drug User Fee Act (PDUFA) calendar for October produced mixed outcomes. PDUFA dates are key binary events for biotech stocks that can move the needle in a...
Via
Benzinga
3 Penny Stocks Insiders Are Buying
October 28, 2021
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider...
Via
Benzinga
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...
Via
Benzinga
56 Biggest Movers From Yesterday
October 26, 2021
Gainers Bakkt Holdings, Inc. (NYSE: BKKT) shares jumped 234.4% to close at $30.60 on Monday after the company and Mastercard announced a partnership for crypto and loyalty...
Via
Benzinga
Mid-Afternoon Market Update: Nasdaq Jumps 150 Points; Bakkt Holdings Shares Spike Higher
October 25, 2021
Toward the end of trading Monday, the Dow traded up 0.26% to 35,771.26 while the NASDAQ rose 1.01% to 15,241.89. The S&P also rose, gaining 0.56% to 4,570.56. The U.S. has the...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Monday's Intraday Session
October 25, 2021
Gainers Jaguar Health (NASDAQ:JAGX) shares increased by 14.64% to $2.08 during Monday's regular session. The current volume of 7.2 million shares is 300.39% of Jaguar...
Via
Benzinga
Mid-Day Market Update: Crude Oil Rises Over 1%; ERYTECH Pharma Shares Plummet
October 25, 2021
Midway through trading Monday, the Dow traded up 0.14% to 35,726.52 while the NASDAQ rose 0.52% to 15,168.16. The S&P also rose, gaining 0.27% to 4,557.07. The U.S. has the...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
35 Stocks Moving In Monday's Mid-Day Session
October 25, 2021
Gainers Greenpro Capital Corp. (NASDAQ: GRNQ) shares jumped 122% to $1.8895 after the company announced its incubated company Angkasa-X has successfully admitted as an ITU-R...
Via
Benzinga
Mid-Morning Market Update: Markets Edge Higher; Kimberly Clark Cuts FY21 Forecast
October 25, 2021
Following the market opening Monday, the Dow traded up 0.07% to 35,700.45 while the NASDAQ rose 0.31% to 15,136.85. The S&P also rose, gaining 0.08% to 4,548.74. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Monday's Pre-Market Session
October 25, 2021
Gainers Kiromic BioPharma (NASDAQ:KRBP) stock increased by 28.64% to $2.47 during Monday's pre-market session. The company's market cap stands at $38.1 million....
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
October 18, 2021
Gainers Valneva (NASDAQ:VALN) stock increased by 35.65% to $38.05 during Monday's pre-market session. The market value of their outstanding shares is at $1.8 billion....
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
October 14, 2021
Gainers NRX Pharmaceuticals (NASDAQ:NRXP) stock increased by 34.63% to $12.71 during Thursday's pre-market session. The company's market cap stands at $683.4...
Via
Benzinga
The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More
October 24, 2021
Biotech stocks posted gains for the second week running, supported by multiple catalysts that included a good start to the big pharma reporting season and broader market strength...
Via
Benzinga
Exposures
Product Safety
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.